These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15115305)

  • 1. The absence of CD44 ameliorates Fas(lpr/lpr) disease.
    Weber GF
    Autoimmunity; 2004 Feb; 37(1):1-8. PubMed ID: 15115305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease.
    Do Y; Rafi-Janajreh AQ; McKallip RJ; Nagarkatti PS; Nagarkatti M
    Int Immunol; 2003 Nov; 15(11):1327-40. PubMed ID: 14565931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.
    McKallip RJ; Do Y; Fisher MT; Robertson JL; Nagarkatti PS; Nagarkatti M
    Int Immunol; 2002 Sep; 14(9):1015-26. PubMed ID: 12202399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional studies of adhesion molecules on CD4-CD8- double negative T cells of autoimmune MRL/Mp-lpr/mice].
    Wang W
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):755-66. PubMed ID: 8225181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.
    Anstee NS; Vandenberg CJ; Campbell KJ; Hughes PD; O'Reilly LA; Cory S
    Cell Death Differ; 2017 Mar; 24(3):397-408. PubMed ID: 27813531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95 (Fas) may control the expansion of activated T cells after elimination of bacteria in murine listeriosis.
    Fuse Y; Nishimura H; Maeda K; Yoshikai Y
    Infect Immun; 1997 May; 65(5):1883-91. PubMed ID: 9125576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.
    Watson ML; Rao JK; Gilkeson GS; Ruiz P; Eicher EM; Pisetsky DS; Matsuzawa A; Rochelle JM; Seldin MF
    J Exp Med; 1992 Dec; 176(6):1645-56. PubMed ID: 1460423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
    Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
    Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
    Sharma J; Collins TD; Roach T; Mishra S; Lam BK; Mohamed ZS; Veal AE; Polk TB; Jones A; Cornaby C; Haider MI; Zeumer-Spataro L; Johnson HM; Morel LM; Larkin J
    Sci Rep; 2021 Mar; 11(1):6354. PubMed ID: 33737712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.
    Skarstein K; Nerland AH; Eidsheim M; Mountz JD; Jonsson R
    Scand J Immunol; 1997 Oct; 46(4):373-8. PubMed ID: 9350288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.